Medclair Targets Tenfold Revenue Growth with Innovative Nitrous Oxide Capture Technology

Medclair, a Swedish cleantech company founded in 2013, is accelerating its market expansion and innovation efforts to make nitrous oxide safe and sustainable. This gas is widely used in healthcare for rapid pain relief during childbirth, emergency procedures, and dentistry, but it is also a potent greenhouse gas and poses workplace risks. Medclair's unique technology captures and neutralizes nitrous oxide emissions at the source, preserving its benefits while mitigating environmental and health hazards.\n\nThe company estimates a total addressable market (TAM) of about 17 billion SEK within OECD countries, with a shorter-term serviceable available market (SAM) of approximately 3 billion SEK, focusing mainly on hospitals and industries across Europe and select Asian regions. Medclair plans to scale its operations significantly, aiming to increase its revenue tenfold within the next five years through innovation, sales growth, and brand awareness initiatives. Key to this strategy is establishing local presence and dedicated sales teams in top markets such as the UK, Germany, France, and the USA to accelerate results.\n\nIn the first half of 2025, Medclair demonstrated strong organic growth in order intake and net revenue while maintaining profitability. Its technology has been internationally recognized as a critical solution to addressing climate and occupational health issues, with over 350 installations across more than 20 countries. CEO Jonas Lundh highlighted that their system provides a climate-friendly alternative that retains nitrous oxide's clinical benefits without endangering staff or the environment. As regulations tighten and global awareness rises, demand for Medclair's solutions is poised to grow rapidly.